切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2020, Vol. 14 ›› Issue (03) : 129 -132. doi: 10.11817/j.issn.1673-9248.2020.03.002

所属专题: 专家论坛 文献

专家论坛

颈动脉支架置入术后脑高灌注综合征的临床研究现状及进展
姚东陂1, 缪中荣2,()   
  1. 1. 100070 首都医科大学附属北京天坛医院神经介入中心,100122 北京朝阳中西医结合急诊抢救中心神经内二科
    2. 100070 首都医科大学附属北京天坛医院神经介入中心
  • 收稿日期:2020-03-19 出版日期:2020-06-01
  • 通信作者: 缪中荣

Clinical research status and progress on cerebral hyperperfusion syndrome after carotid stenting

Dongpo Yao1, Zhongrong Miao2,()   

  1. 1. Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China, Department of Neurology, Beijing Chaoyang Integrative Medicine Emergency Medical Center, Beijing 100122, China
    2. Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
  • Received:2020-03-19 Published:2020-06-01
  • Corresponding author: Zhongrong Miao
  • About author:
    Corresponding author: Miao Zhongrong, Email:
引用本文:

姚东陂, 缪中荣. 颈动脉支架置入术后脑高灌注综合征的临床研究现状及进展[J/OL]. 中华脑血管病杂志(电子版), 2020, 14(03): 129-132.

Dongpo Yao, Zhongrong Miao. Clinical research status and progress on cerebral hyperperfusion syndrome after carotid stenting[J/OL]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2020, 14(03): 129-132.

症状性颈动脉狭窄是脑卒中的重要病因,针对其治疗的颈动脉支架置入术(CAS)目前已在临床普遍开展。脑高灌注综合征(CHS)是CAS术后的严重并发症之一。本文将对CAS术后CHS的流行病学特点、发病机制、危险因素、临床表现、辅助检查、诊断及其预防治疗的研究现状及进展进行综述,以指导临床实践。

Symptomatic carotid stenosis is a major cause of stroke, and carotid artery stenting (CAS) has been widely used in clinical practice. Cerebral hyperperfusion syndrome (CHS) is a severe complication post CAS. This review covers the current status and progress of CHS after CAS, including the epidemiology, pathogenesis, risk factors, clinical manifestations, assistant examination, diagnosis, prevention, and treatment, in order to guide clinical practice.

1
王荣耀, 王勇. 颈动脉狭窄行颈动脉内膜切除术后应用不同剂量阿司匹林效果及安全性分析 [J]. 中国临床医生杂志, 2018, 46(01): 75-77.
2
贾子昌, 卞焕菊, 韩金涛, 等. 颈动脉支架成形术后脑高灌注综合征 [J]. 北京大学学报(医学版), 2019, 51(04): 733-736.
3
Zhang Y, Kumar A, Tezel JB, et al. Imaging Evidence for Cerebral Hyperperfusion Syndrome after Intravenous TissuePlasminogen Activator for Acute Ischemic Stroke [J]. Case Rep Neurol Med, 2016, 2016: 8725494.
4
李宝民, 缪中荣, 王拥军, 等. 症状性颅内动脉粥样硬化性狭窄血管内治疗中国专家共识2018 [J]. 中国卒中杂志, 2018, 13(06): 594-604.
5
Galyfos G, Sianou A, Filis K. Cerebral hyperperfusion syndrome and intracranial hemorrhage after carotid endarterectomy or carotid stenting:ameta-analysis [J]. J Neurol Sci, 2017, 381: 74-82.
6
González García A, Moniche F, Escudero-Martínez I, et al. Clinical predictors of hyperperfusion syndrome following carotid stenting: Results From a National Prospective Multicenter Study [J]. JACC Cardiovasc Interv, 2019, 12(09): 873-882.
7
邱永逸, 陈劲草, 章剑剑, 等. 成人烟雾病STA-MCA分流术联合EMS后脑出血和高灌注综合征的关系 [J]. 中国临床神经外科杂志, 2019, 24(07): 387-389.
8
Andereggen L, Amin-Hanjani S, El-Koussy M, et al. Quantitative magnetic resonance angiography as a potential predictor for cerebral hyperperfusion syndrome: a preliminary study [J]. J Neurosurg, 2017, 128(04): 1-9.
9
Nomura S, Yamaguchi K, Ishikawa T, et al. Factors of delayed hyperperfusion and the importance of repeated cerebral blood flow evaluation for hyperperfusion after direct bypass for Moyamoya Disease [J]. World Neurosurg, 2018, 118: e468-e472.
10
Ishikawa T, Yamaguchi K, Kawashima A, et al. Predicting the occurrence of hemorrhagic cerebral hyperperfusion syndrome using regional cerebral blood flow after direct bypass surgery in patients with Moyamoya Disease [J]. World Neurosurg, 2018, 119: e750-e756.
11
Kneihsl M, Niederkorn K, Deutschmann H, et al. Increased middle cerebral artery mean blood flow velocity index after stroke thrombectomy indicate increased risk for intracranial hemorrhage [J]. J Neurointerv Surg, 2018, 10(09): 882-887.
12
Yamamoto D, Hosoda K, Uchihashi Y, et al. Perioperative changes in cerebral perfusion territories assessed by arterial spin labeling magnetic resonance imaging are associated with postoperative increases in cerebral blood flow in patients with carotid stenosis [J]. World Neurosurg, 2017, 102(06): 477-486.
13
Medel R, Crowley RW, Dumont AS. Hyperperfusion syndrome following endovascular cerebral revascularization [J]. Neurosurg Focus, 2009, 26(03): E4.
14
陆培琴, 洪丽燕, 王双虎, 等. 预防性安置临时起搏器对颈动脉支架植入术病人颈动脉窦反应及并发症的影响 [J]. 中西医结合心脑血管病杂志, 2018, 16(13): 1938-1940.
15
Hashimoto T, Matsumoto S, Ando M, et al. Cerebral hyperperfusion syndrome after endovascular reperfusion therapy in a patient with acute internal carotid artery and middle cerebral artery occlusions [J]. World Neurosurg, 2018, 110: 145-151.
16
方运勇, 王亚, 梁福晓, 等. 磁共振成像用于高灌注性脑病临床诊断的表现及特征研究 [J]. 中国医学工程, 2018, 26(09): 9-11.
17
李颜, 白小欣, 蔡军. 颈内动脉支架成形术后高灌注综合征3例分析 [J]. 中西医结合心脑血管病杂志, 2018, 16(09): 1308-1309.
18
Wang SB, Han J, Cheng L, et al. Risk factors and preventive measures of cerebral hyperperfusion syndrome after carotid artery interventional therapy [J]. Exp Ther Med, 2017, 14(03): 2517-2520.
19
Wang GJ, Beck AW, De Martino RR. Insight into the cerebral hyperperfusion syndrome following carotid endarterectomy from the national Vascular Quality Initiative [J]. J Vasc Surg, 2017, 65(02): 381-389.
20
Hussain MA, Alali AS, Mamdani M, et al. Risk of intracranial hemorrhage after carotid artery stenting versus endarterectomy: a population-based study [J]. J Neurosurg, 2018, 129(06): 1-8.
21
柳雅洁, 袁军. 经颅多普勒超声在评估与诊断血管再通后脑高灌注综合征的应用 [J].内蒙古医学杂志, 2019, 51(08): 950-952.
22
郭京华, 唐守现, 彭伟, 等. 缺血性脑血管病患者FLAIR血管高信号征三种评分方法的一致性研究 [J]. 磁共振成像, 2018, 09(05): 340-345.
23
李桥, 高心逸, 胡海梦. CT灌注成像评价急性缺血性脑梗死患者侧支循环变化 [J]. 中国临床神经科学, 2018, 26(04): 374-382.
24
Tseng YC, Hsu HL, Lee TH, et al. Prediction of cerebral hyperperfusion syndrome after carotid stenting: a cerebral perfusion computed tomography study [J]. J Comput Assist Tomogr, 2009, 33(04): 540-545.
25
Park HS, Nakagawa I, Yokoyama S, et al. Amplitude of tissue oxygenation index change predicts cerebralhyperperfusion syndrome during carotid artery stenting [J]. World Neurosurg, 2017, 99: 548-555.
26
Misaki K, Uchiyama N, Inaki A, et al. Objective evaluation of cerebrovascular reactivity for acetazolamide predicts cerebral hyperperfusion after carotid artery stenting:comparison with region of interest methods [J]. J Neuroradiol, 2018, 45(06): 362-367.
27
Yamauchi K, Enomoto Y, Otani K, et al. Prediction of hyperperfusion phenomenon after carotid artery stenting and carotid angioplasty using quantitative DSA with cerebral circulation time imaging [J]. J Neurointerv Surg, 2018, 10(06): 576-579.
28
Leslie-Mazwi T, Chen M, Yi J, et al. Post-thrombectomy management Of the ELVO patient: Guidelines from the Society of Neuro Interventional Surgery [J]. J Neurointerv Surg, 2017, 09(12): 1258-1266.
29
Abou-Chebl A,Reginelli J,Bajzer CT,et al. Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting [J]. Catheter Cardiovasc Interv,2007,69(05): 690-696.
30
Kirchoff-Torres KF, Bakradze E. Cerebral hyperperfusion syndrome after carotid revascularization and acute ischemic stroke [J]. Curr Pain Headache Rep, 2018, 22(04): 24.
31
Nair AS. Benefits of using dexmedetomidine during carotid endarterectomy: A review [J]. Saudi J Anaesth, 2014, 08(02): 264-267.
32
Milgrom D, Hajibandeh S, Hajibandeh S, et al. Editor’s choice dystematic review and meta-analysis of very urgent carotidintervention for symptomatic carotid disease [J]. Eur J Vasc Endovasc Surg, 2018, 56(05): 622-631.
33
Wu F, Huang L, Lu G, et al. Two-stage cerebral hemodynamic changes in staged carotid angioplasty and stenting [J]. J Stroke Cerebrovasc Dis, 2016, 25(12): 2814-2820.
34
Uchida K, Yoshimura S, Shirakawa M, et al. Experience of staged angioplasty to avoid hyperperfusion syndrome for carotid artery stenosis [J]. Neurol Med Chir (Tokyo), 2015, 55(11): 824-829.
35
刘文静, 黄照河, 郭灿收, 等. 多发颅内外动脉狭窄支架植入术后脑高灌注综合征一例 [J]. 右江民族医学院学报, 2018, 40(02): 182-184.
36
Farooq MU, Goshgarian C, Min J, et al. Pathophysiology and management of reperfusion injury and hyperperfusion syndrome after carotid endarterectomy and carotid artery stenting [J]. Exp Transl Stroke Med, 2016, 08(01): 7.
37
Matano F, Murai Y, Mizunari T, et al. Intracerebral hemorrhagecaused by cerebral hyperperfusion after superficial temporal artery to middle cerebral artery bypass for atherosclerotic occlusive cerebrovascular disease [J]. NMC Case Rep J, 2016, 04(01): 27-32.
[1] 李雪, 韩萌萌, 冯雪园, 马宁. 人表皮生长因子受体2低表达乳腺癌的研究进展及挑战[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 308-312.
[2] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[3] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[4] 何羽. 腔镜微创手术治疗分化型甲状腺癌的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 456-458.
[5] 赵淑樱, 张聃. 腹腔镜胃癌外科治疗进展与发展趋势[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 459-462.
[6] 刘璐璐, 何羽. 慢性阻塞性肺病患者睡眠障碍的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 836-839.
[7] 张瑜, 姜梦妮. 基于DWI信号值构建局部进展期胰腺癌放化疗生存获益预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 657-664.
[8] 王哲学, 白峻阁, 姜得地, 李月刚, 杨明, 陈海鹏, 刘正. 局部进展期直肠癌经新辅助放化疗后肿瘤退缩分级及预后的影响因素分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 368-374.
[9] 国文凯, 纪鹏程, 毕靖茹, 谢院生. IgA 肾病的十种治疗措施[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 327-333.
[10] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[11] 丁洪基, 赵长江, 孙鹏飞, 王灿, 王贵珍, 李龙龙. 细胞焦亡与疾病的关系研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 682-686.
[12] 黄宏山, 陈成彩. 经淋巴管超声造影在乳腺癌前哨淋巴结诊断中的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 411-414.
[13] 钟小军, 杨清峰, 邹忠元, 丘宁宁, 李见英, 邹四珍, 黄小琴, 郭冠华, 牛立志. 支气管镜联合数字减影血管造影在恶性气道狭窄金属支架置入中的应用[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 317-322.
[14] 王丽娜, 吕书霞, 李亚男. 脑卒中偏瘫患者健康焦虑元认知与疾病接受度、恐惧疾病进展的相关性[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 434-440.
[15] 刘焕亮, 崔慧娟, 曹慧, 付源. 颈动脉狭窄处剪切率对高同型半胱氨酸血症患者脑梗死的预测价值[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 317-322.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?